Variant report

Variant	nsv976506
Chromosome Location	chr11:107675189-107680893
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:107673752..107675731-chr11:107729272..107731917,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000110660	chromatin interactions

Extended variants
information (count: 258 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:258 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs374680991	chr11:107675237-107675238	Weak transcription Genic enhancers Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs568634934	chr11:107675262-107675263	Weak transcription Genic enhancers Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs190372046	chr11:107675299-107675300	Weak transcription Genic enhancers Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs139487495	chr11:107675300-107675301	Weak transcription Genic enhancers Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs116790350	chr11:107675306-107675307	Weak transcription Genic enhancers Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs543980052	chr11:107675319-107675320	Weak transcription Genic enhancers Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs535234879	chr11:107675323-107675324	Weak transcription Genic enhancers Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs149689966	chr11:107675385-107675386	Weak transcription Genic enhancers Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs373252267	chr11:107675403-107675404	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs376357360	chr11:107675460-107675461	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs184602466	chr11:107675467-107675468	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs372052211	chr11:107675517-107675518	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs200799404	chr11:107675533-107675534	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs182970449	chr11:107675560-107675561	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs495836	chr11:107675566-107675567	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs545486499	chr11:107675597-107675598	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs544301791	chr11:107675616-107675617	Weak transcription Strong transcription Genic enhancers Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs547430767	chr11:107675684-107675685	Weak transcription Strong transcription Genic enhancers Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs4379794	chr11:107675707-107675708	Weak transcription Strong transcription Genic enhancers Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs17107492	chr11:107675710-107675711	Weak transcription Strong transcription Genic enhancers Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs147284887	chr11:107675716-107675717	Weak transcription Strong transcription Genic enhancers Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs552542936	chr11:107675725-107675726	Weak transcription Strong transcription Genic enhancers Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs570655995	chr11:107675785-107675786	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs78537250	chr11:107675787-107675788	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs561801459	chr11:107675805-107675806	Weak transcription Enhancers Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs187480410	chr11:107675811-107675812	Weak transcription Enhancers Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs79876525	chr11:107675896-107675897	Weak transcription Enhancers Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs535385031	chr11:107675954-107675955	Weak transcription Enhancers Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs556694084	chr11:107675956-107675957	Weak transcription Enhancers Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs192447641	chr11:107675983-107675984	Weak transcription Enhancers Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs578054517	chr11:107676020-107676021	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs367755820	chr11:107676041-107676042	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs370302669	chr11:107676056-107676057	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs374635369	chr11:107676073-107676074	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs201831509	chr11:107676101-107676102	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs147722849	chr11:107676104-107676105	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs377095277	chr11:107676117-107676118	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs368409378	chr11:107676130-107676131	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs184076923	chr11:107676146-107676147	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs372858803	chr11:107676159-107676160	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs374815759	chr11:107676190-107676191	Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs367773970	chr11:107676213-107676214	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs199578545	chr11:107676219-107676220	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs71488279	chr11:107676260-107676261	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs550528963	chr11:107676307-107676308	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs187688345	chr11:107676339-107676340	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs574053682	chr11:107676365-107676366	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs17107496	chr11:107676373-107676374	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs562729931	chr11:107676383-107676384	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs143463654	chr11:107676384-107676385	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Basal cell lymphoma	16790693	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Intracranial aneurysm	16715129	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Ovarian cancer	21720365	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mantle cell lymphoma	19029149	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Obesity	19966786	CNVD
Renal cell carcinoma	21668985	CNVD
Cancer	20164920	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:167 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:107654000-107676800	Weak transcription	NH-A	brain
2	chr11:107656600-107679800	Weak transcription	Osteobl	bone
3	chr11:107658800-107679000	Weak transcription	H1 Cell Line	embryonic stem cell
4	chr11:107658800-107680600	Weak transcription	Small Intestine	intestine
5	chr11:107659000-107679200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
6	chr11:107659400-107679200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
7	chr11:107660800-107676800	Weak transcription	Primary T cells fromperipheralblood	blood
8	chr11:107661000-107678600	Weak transcription	Lung	lung
9	chr11:107661000-107693200	Weak transcription	Spleen	Spleen
10	chr11:107661200-107676000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
11	chr11:107661600-107679600	Weak transcription	H9 Cell Line	embryonic stem cell
12	chr11:107661800-107675600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
13	chr11:107661800-107679200	Weak transcription	Aorta	Aorta
14	chr11:107661800-107680600	Weak transcription	Primary T helper cells PMA-I stimulated	--
15	chr11:107661800-107685800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
16	chr11:107661800-107691800	Weak transcription	Esophagus	oesophagus
17	chr11:107662200-107681000	Weak transcription	Hela-S3	cervix
18	chr11:107662400-107675800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
19	chr11:107662400-107682800	Weak transcription	Pancreas	Pancrea
20	chr11:107662400-107686400	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr11:107662800-107683800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
22	chr11:107663000-107682800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
23	chr11:107663000-107683400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
24	chr11:107663000-107683600	Weak transcription	Rectal Smooth Muscle	rectum
25	chr11:107663200-107684200	Weak transcription	HepG2	liver
26	chr11:107663200-107690200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
27	chr11:107663600-107676000	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
28	chr11:107663600-107679000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr11:107663600-107682200	Weak transcription	Ovary	ovary
30	chr11:107664000-107676400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr11:107664600-107683800	Weak transcription	Stomach Mucosa	stomach
32	chr11:107664600-107686000	Weak transcription	Gastric	stomach
33	chr11:107665200-107675800	Weak transcription	NHEK	skin
34	chr11:107665800-107675800	Weak transcription	Primary hematopoietic stem cells	blood
35	chr11:107666200-107680600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
36	chr11:107667800-107676200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr11:107670200-107680600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
38	chr11:107670800-107685000	Strong transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
39	chr11:107671200-107677600	Strong transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr11:107671200-107682600	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr11:107671200-107682600	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr11:107671600-107685000	Strong transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr11:107671600-107685800	Weak transcription	HSMM	muscle
44	chr11:107671600-107686200	Weak transcription	NHDF-Ad	bronchial
45	chr11:107672000-107697000	Weak transcription	Sigmoid Colon	Sigmoid Colon
46	chr11:107672200-107677800	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr11:107672800-107687800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
48	chr11:107673000-107682400	Strong transcription	Primary B cells from peripheral blood	blood
49	chr11:107673000-107683200	Strong transcription	HUVEC	blood vessel
50	chr11:107673400-107727800	Weak transcription	Primary B cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links